225 related articles for article (PubMed ID: 25338520)
21. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
[TBL] [Abstract][Full Text] [Related]
22. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
[TBL] [Abstract][Full Text] [Related]
23. pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.
Soubeyran I; Quénel N; Coindre JM; Bonichon F; Durand M; Wafflart J; Mauriac L
Br J Cancer; 1996 Oct; 74(7):1120-5. PubMed ID: 8855985
[TBL] [Abstract][Full Text] [Related]
24. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S
Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614
[TBL] [Abstract][Full Text] [Related]
25. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
[TBL] [Abstract][Full Text] [Related]
26. Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment.
Mantovani G; Macciò A; Madeddu C; Mura L; Massa E; Gramignano G; Lusso MR; Murgia V; Camboni P; Ferreli L
J Cell Mol Med; 2002; 6(4):570-82. PubMed ID: 12611641
[TBL] [Abstract][Full Text] [Related]
27. The prevalence and significance of oestrogen receptor (ER) positivity in breast cancer at the University Hospital of the West Indies, Jamaica.
Alfred R; Chin SN; Williams E; Walters C; Barton EN; Shah D
West Indian Med J; 2012 Nov; 61(8):795-801. PubMed ID: 23757900
[TBL] [Abstract][Full Text] [Related]
28. IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.
Markkula A; Simonsson M; Ingvar C; Rose C; Jernström H
BMC Cancer; 2014 Oct; 14():759. PubMed ID: 25305747
[TBL] [Abstract][Full Text] [Related]
29. Combination of Endogenous Estradiol and Adipokine Leptin in Breast Cancer Risk and Prognosis Assessment in Postmenopausal Chinese Women.
Luo Y; Li HB; Zhang Y; Wu YX; Shen D; Che YQ
Front Endocrinol (Lausanne); 2021; 12():766463. PubMed ID: 34970222
[TBL] [Abstract][Full Text] [Related]
30. Association of oxidative stress biomarkers with adiposity and clinical staging in women with breast cancer.
Carioca AA; Verde SM; Luzia LA; Rondó PH; Latorre MR; Ellery TH; Damasceno NR
Eur J Clin Nutr; 2015 Nov; 69(11):1256-61. PubMed ID: 26039316
[TBL] [Abstract][Full Text] [Related]
31. Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters.
Mantovani G; Madeddu C; Gramignano G; Lusso MR; Mocci M; Massa E; Ferreli L; Astara G; Macciò A; Serpe R
J Exp Ther Oncol; 2003; 3(4):205-19. PubMed ID: 14567291
[TBL] [Abstract][Full Text] [Related]
32. Insulin use, adipokine profiles and breast cancer prognosis.
Wintrob ZA; Hammel JP; Khoury T; Nimako GK; Fu HW; Fayazi ZS; Gaile DP; Forrest A; Ceacareanu AC
Cytokine; 2017 Jan; 89():45-61. PubMed ID: 27914795
[TBL] [Abstract][Full Text] [Related]
33. Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome.
Ece A; Atamer Y; Gürkan F; Bilici M; Koçyiğit Y
Nephrology (Carlton); 2004 Dec; 9(6):366-73. PubMed ID: 15663638
[TBL] [Abstract][Full Text] [Related]
34. Tissue leptin levels in patients with breast cancer.
Karaduman M; Bilici A; Ozet A; Sengul A; Musabak U; Alomeroglu M
J BUON; 2010; 15(2):369-72. PubMed ID: 20658737
[TBL] [Abstract][Full Text] [Related]
35. Interrelations among the adipocytokines leptin and adiponectin, oxidative stress and aseptic inflammation markers in pre- and early-pubertal normal-weight and obese boys.
Paltoglou G; Schoina M; Valsamakis G; Salakos N; Avloniti A; Chatzinikolaou A; Margeli A; Skevaki C; Papagianni M; Kanaka-Gantenbein C; Papassotiriou I; Chrousos GP; Fatouros IG; Mastorakos G
Endocrine; 2017 Mar; 55(3):925-933. PubMed ID: 28092067
[TBL] [Abstract][Full Text] [Related]
36. Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
Wang F; Liu L; Cui S; Tian F; Fan Z; Geng C; Cao X; Yang Z; Wang X; Liang H; Wang S; Jiang H; Duan X; Wang H; Li G; Wang Q; Zhang J; Jin F; Tang J; Li L; Zhu S; Zuo W; Ma Z; Zhou F; Yu L; Xiang Y; Li L; Shen S; Yu Z
Oncologist; 2017 Dec; 22(12):1431-1443. PubMed ID: 28912152
[TBL] [Abstract][Full Text] [Related]
37. Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues.
Heng YJ; Wang J; Ahearn TU; Brown SB; Zhang X; Ambrosone CB; de Andrade VP; Brufsky AM; Couch FJ; King TA; Modugno F; Vachon CM; DuPre NC; Garcia-Closas M; Troester MA; Hunter DJ; Eliassen AH; Tamimi RM; Hankinson SE; Beck AH
Breast Cancer Res Treat; 2019 Feb; 173(3):667-677. PubMed ID: 30387004
[TBL] [Abstract][Full Text] [Related]
38. Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesteron receptor status.
Maehle BO; Tretli S; Skjaerven R; Thorsen T
Breast Cancer Res Treat; 2001 Jul; 68(2):159-69. PubMed ID: 11688519
[TBL] [Abstract][Full Text] [Related]
39. The effect of increasing body mass index on cardio-metabolic risk and biomarkers of oxidative stress and inflammation in nascent metabolic syndrome.
Pahwa R; Adams-Huet B; Jialal I
J Diabetes Complications; 2017 May; 31(5):810-813. PubMed ID: 28285929
[TBL] [Abstract][Full Text] [Related]
40. Molecular hydrogen reduces acute exercise-induced inflammatory and oxidative stress status.
Nogueira JE; Passaglia P; Mota CMD; Santos BM; Batalhão ME; Carnio EC; Branco LGS
Free Radic Biol Med; 2018 Dec; 129():186-193. PubMed ID: 30243702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
